<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
        xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
  <url>
    <loc>https://retacompare.com/news/pediatric-obesity-treatment-insights-from-adult-weight-loss-medications</loc>
    <lastmod>2026-11-01T01:30:23.324Z</lastmod>
    <news:news>
      <news:publication>
        <news:name>RetatrutideCompare</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-01T01:30:23.324Z</news:publication_date>
      <news:title>Pediatric Obesity Treatment Insights from Adult Weight-Loss Medications</news:title>
      <news:keywords>Weight Loss, Retatrutide</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://retacompare.com/news/exploring-urological-effects-in-obesity-implications-for-glp-1-research</loc>
    <lastmod>2026-10-31T01:30:42.534Z</lastmod>
    <news:news>
      <news:publication>
        <news:name>RetatrutideCompare</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-31T01:30:42.534Z</news:publication_date>
      <news:title>Exploring Urological Effects in Obesity: Implications for GLP-1 Research</news:title>
      <news:keywords>Weight Loss, Retatrutide</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://retacompare.com/news/teen-discusses-glp-1-drug-s-effect-on-daily-life</loc>
    <lastmod>2026-10-31T00:52:11.000Z</lastmod>
    <news:news>
      <news:publication>
        <news:name>RetatrutideCompare</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-31T00:52:11.000Z</news:publication_date>
      <news:title>Teen Discusses GLP-1 Drug&apos;s Effect on Daily Life</news:title>
      <news:keywords>Patient Experiences, Retatrutide</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://retacompare.com/news/glp-1-agonists-linked-to-cardiovascular-outcomes-in-masld-patients</loc>
    <lastmod>2026-10-31T00:00:00.000Z</lastmod>
    <news:news>
      <news:publication>
        <news:name>RetatrutideCompare</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-31T00:00:00.000Z</news:publication_date>
      <news:title>GLP-1 Agonists Linked to Cardiovascular Outcomes in MASLD Patients</news:title>
      <news:keywords>Clinical Trials, Retatrutide</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://retacompare.com/news/crf2-agonism-shows-potential-in-obesity-treatment-with-muscle-and-glucose-benefits</loc>
    <lastmod>2026-10-31T00:00:00.000Z</lastmod>
    <news:news>
      <news:publication>
        <news:name>RetatrutideCompare</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-31T00:00:00.000Z</news:publication_date>
      <news:title>CRF2 Agonism Shows Potential in Obesity Treatment with Muscle and Glucose Benefits</news:title>
      <news:keywords>Weight Loss, Retatrutide</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://retacompare.com/news/glp-1-agonist-use-in-obese-endometrial-cancer-patients-explored</loc>
    <lastmod>2026-10-31T00:00:00.000Z</lastmod>
    <news:news>
      <news:publication>
        <news:name>RetatrutideCompare</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-31T00:00:00.000Z</news:publication_date>
      <news:title>GLP-1 Agonist Use in Obese Endometrial Cancer Patients Explored</news:title>
      <news:keywords>Clinical Trials, Retatrutide</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://retacompare.com/news/gipr-loss-in-neurons-doesn-t-hinder-glp-1-weight-loss-with-antagonism</loc>
    <lastmod>2026-10-31T00:00:00.000Z</lastmod>
    <news:news>
      <news:publication>
        <news:name>RetatrutideCompare</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-31T00:00:00.000Z</news:publication_date>
      <news:title>GIPR Loss in Neurons Doesn&apos;t Hinder GLP-1 Weight Loss with Antagonism</news:title>
      <news:keywords>Weight Loss, Retatrutide</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://retacompare.com/news/retatrutide-shows-potential-in-alleviating-sleep-apnea-symptoms</loc>
    <lastmod>2026-10-30T20:43:55.000Z</lastmod>
    <news:news>
      <news:publication>
        <news:name>RetatrutideCompare</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-30T20:43:55.000Z</news:publication_date>
      <news:title>Retatrutide Shows Potential in Alleviating Sleep Apnea Symptoms</news:title>
      <news:keywords>Clinical Trials, Retatrutide</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://retacompare.com/news/experimental-drug-retatrutide-shows-potential-in-reducing-sleep-apnea-symptoms</loc>
    <lastmod>2026-10-30T19:49:25.000Z</lastmod>
    <news:news>
      <news:publication>
        <news:name>RetatrutideCompare</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-30T19:49:25.000Z</news:publication_date>
      <news:title>Experimental Drug Retatrutide Shows Potential in Reducing Sleep Apnea Symptoms</news:title>
      <news:keywords>Weight Loss, Retatrutide</news:keywords>
    </news:news>
  </url>
</urlset>
